175 related articles for article (PubMed ID: 23442735)
21. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
22. Molecular pathology of early pancreatic cancer.
Remmers N; Bailey JM; Mohr AM; Hollingsworth MA
Cancer Biomark; 2010; 9(1-6):421-40. PubMed ID: 22112488
[TBL] [Abstract][Full Text] [Related]
23. Molecular signatures of pancreatic cancer.
Hong SM; Park JY; Hruban RH; Goggins M
Arch Pathol Lab Med; 2011 Jun; 135(6):716-27. PubMed ID: 21631264
[TBL] [Abstract][Full Text] [Related]
24. TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions.
Cohen AS; Li J; Hight MR; McKinley E; Fu A; Payne A; Liu Y; Zhang D; Xie Q; Bai M; Ayers GD; Tantawy MN; Smith JA; Revetta F; Washington MK; Shi C; Merchant N; Manning HC
Clin Cancer Res; 2020 Nov; 26(22):5914-5925. PubMed ID: 32933996
[TBL] [Abstract][Full Text] [Related]
25. WHO-classification 2000: exocrine pancreatic tumors.
Klöppel G; Lüttges J
Verh Dtsch Ges Pathol; 2001; 85():219-28. PubMed ID: 11894402
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
[TBL] [Abstract][Full Text] [Related]
27. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.
Distler M; Aust D; Weitz J; Pilarsky C; Grützmann R
Biomed Res Int; 2014; 2014():474905. PubMed ID: 24783207
[TBL] [Abstract][Full Text] [Related]
28. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
Distler M; Welsch T; Aust D; Weitz J; Grützmann R
Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
[TBL] [Abstract][Full Text] [Related]
29. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
30. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.
Furukawa T; Klöppel G; Volkan Adsay N; Albores-Saavedra J; Fukushima N; Horii A; Hruban RH; Kato Y; Klimstra DS; Longnecker DS; Lüttges J; Offerhaus GJ; Shimizu M; Sunamura M; Suriawinata A; Takaori K; Yonezawa S
Virchows Arch; 2005 Nov; 447(5):794-9. PubMed ID: 16088402
[TBL] [Abstract][Full Text] [Related]
31. The Evolving Role of Pathology in New Developments, Classification, Terminology, and Diagnosis of Pancreatobiliary Neoplasms.
Reid MD; Lewis MM; Willingham FF; Adsay NV
Arch Pathol Lab Med; 2017 Mar; 141(3):366-380. PubMed ID: 28055239
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
Henry JC; Bassi C; Giovinazzo F; Bloomston M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
[TBL] [Abstract][Full Text] [Related]
33. Current topics on precursors to pancreatic cancer.
Takaori K; Hruban RH; Maitra A; Tanigawa N
Adv Med Sci; 2006; 51():23-30. PubMed ID: 17357272
[TBL] [Abstract][Full Text] [Related]
34. Neoplastic Progression in Macroscopic Precursor Lesions of the Pancreas.
Thompson ED
Arch Pathol Lab Med; 2024 Feb; ():. PubMed ID: 38386006
[TBL] [Abstract][Full Text] [Related]
35. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach.
Katabi N; Klimstra DS
J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: Histopathology, Cytopathology, and Molecular Pathology.
Ren B; Liu X; Suriawinata AA
Am J Pathol; 2019 Jan; 189(1):9-21. PubMed ID: 30558727
[TBL] [Abstract][Full Text] [Related]
37. [Pathologic characteristics and evaluation of the pancreatic cancer].
Fukushima N; Mukai K
Gan To Kagaku Ryoho; 2005 May; 32(5):599-604. PubMed ID: 15918557
[TBL] [Abstract][Full Text] [Related]
38. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.
Hruban RH; Adsay NV; Albores-Saavedra J; Compton C; Garrett ES; Goodman SN; Kern SE; Klimstra DS; Klöppel G; Longnecker DS; Lüttges J; Offerhaus GJ
Am J Surg Pathol; 2001 May; 25(5):579-86. PubMed ID: 11342768
[TBL] [Abstract][Full Text] [Related]
40. Updates in the Diagnosis of Intraductal Neoplasms of the Pancreas.
Assarzadegan N; Babaniamansour S; Shi J
Front Physiol; 2022; 13():856803. PubMed ID: 35309060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
